Intrinsic value of Columbia Small Cap Value Fund II Class A (COVAX)
Live fair value data for Columbia Small Cap Value Fund II Class A (COVAX) is currently unavailable. Please check again shortly.
Current Price: $425.00
Valuation: Overvalued
Confidence: 6.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Columbia Small Cap Value Fund II Class A (COVAX) undervalued or overvalued?
Based on the current model output, Columbia Small Cap Value Fund II Class A appears to be overvalued with a downside of 22.00%.
Fair value vs market price — Columbia Small Cap Value Fund II Class A (COVAX)
Unlock premium access to view the live fair value comparison against current market price for COVAX.
Frequently Asked Questions - COVAX
How is COVAX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for COVAX.
Is COVAX undervalued or overvalued right now?
COVAX is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for COVAX: open their intrinsic value pages.
- DISSXBNY Mellon Small Cap Stock Index Fund Investor Shares
- WHGSXWestwood Quality SmallCap Fund Institutional Class
- TQSMXT. Rowe Price Integrated US SMCC Eq
- BEMIXBrandes Emerging Markets Value Fund Class I
- POVSXPutnam International Equity Fd Class A
- DHMIXDiamond Hill Small Mid Cap Fund Class I
- VVisa Inc.
- CCitigroup Inc.